Novio Tech Campus

Khondrion completes enrollment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders

NIJMEGEN, the Netherlands – 10 January 2022: Khondrion, a clinical stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, today announced that the last patient has been dosed with sonlicromanol in the

Lightyear continues their partnership with NXP Semiconductors to support the development of their solar vehicles

Lightyear announced that they will be continuing their collaboration with NXP Semiconductors. With this announcement, they are one step closer to bringing the first solar electric vehicle on the road. The collaboration started in

Protinhi Therapeutics selected as part of BLUE KNIGHT™ collaboration for pandemic preparedness

Protinhi Therapeutics, a company specializing in protease inhibition with the aim to combat viral infectious diseases, has announced that it has been selected to join Blue Knight, a global community of early-stage biotech companies.